Drug Type Small molecule drug |
Synonyms CZC 54252, CZC54252 |
Target |
Mechanism LRRK2 inhibitors(Leucine-rich repeat serine/threonine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC22H25ClN6O4S |
InChIKeyCLGWUCNXOBLWFM-UHFFFAOYSA-N |
CAS Registry1191911-27-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Discovery | DE | - |